Resumen de Management of infection and febrile neutropenia in patients with solid cancer
Juan Antonio Virizuela Echaburu, Jordi Carratalà Fernández, José María Aguado García, David Vicente Baz, Miguel Salavert Lletí, M. Ruiz, Isabel Ruiz Camps, Francesc Marco, Manuel Lizasoain, P. Jiménez Fonseca, C. Gudiol, Javier Cassinello Espinosa, Alberto Carmona Bayonas, Manuela Aguilar Guisado, Juan Jesús Cruz Hernández
An expert group from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, for its acronym in Spanish) and the Spanish Society of Medical Oncology (SEOM, for its acronym in Spanish) have reviewed the main aspects to be considered when evaluating patients with solid cancer and infectious complications contained in this article. Recommendations have, therefore, been put forth regarding the prophylaxis of the most prevalent infections in these patients, the use of vaccines, measures to control infection through vascular catheters, and preventing infection in light of certain surgical maneuvers. The following is a revision of the criteria for febrile neutropenia management and the use of colony-stimulating factors and closes with several guidelines for treating the cancer patient with serious infection. The document concludes with a series of measures to control hospital infection.
